ANNETTE CRUZ: Open Payments
NPI 1235326976 · CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$556 in 11 payments from 7 companies in 2025. Trend: 2023 $144 · 2024 $451 · 2025 $556
Food & beverage: $556
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 3 | $162 |
| EMD Serono, Inc. | 1 | $133 |
| Neurocrine BioSciences, Inc. | 1 | $127 |
| Braintree Laboratories, Inc. | 2 | $49 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
| Merck Sharp & Dohme LLC | 1 | $33 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
Products named: WATCHMAN FLX, INGREZZA, SUTAB, XIFAXAN, KEYTRUDA, Axonics, REBYOTA.
Industry payments across SC — which companies pay providers there.
